The association between RET (Ret Proto-Oncogene) and Hepatocellular Carcinoma is a manually-curated gene–disease association, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.
Sources2
Clinical variants1
Symptoms16
Compounds4
Trials501of 1,696 via RET compounds
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.